A detailed history of Measured Risk Portfolios, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Measured Risk Portfolios, Inc. holds 224 shares of LLY stock, worth $194,219. This represents 0.18% of its overall portfolio holdings.

Number of Shares
224
Holding current value
$194,219
% of portfolio
0.18%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$727.2 - $932.06 $162,892 - $208,781
224 New
224 $173 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $824B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Measured Risk Portfolios, Inc. Portfolio

Follow Measured Risk Portfolios, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Measured Risk Portfolios, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Measured Risk Portfolios, Inc. with notifications on news.